CVC selling block of up to HK$620 mln in Jintian Pharma -term sheet

Universal Health International Holding

07/10/2014 10:21

HONG KONG, Oct 7 (Reuters) - Global private equity firm CVC 
Capital Partners  CVC.UL  is selling a block of shares worth up 
to HK$620 million ($79.95 million) in pharmaceutical retailer 
Jintian Pharmaceutical Group Ltd  2211.HK , according to a term 
sheet seen by Reuters on Tuesday.  
    CVC is selling the shares in a range of HK$3.29 to HK$3.34 
per share, a discount of 3.5 percent to 4.9 percent to the Oct. 
7 closing price of Jintian Pharma.  
    CVC invested $84.1 million to acquire a stake of 24.24 
percent in Jintian Pharma in October 2011, according to the 
private equity firm's website.  
    CVC is selling the shares out of AMG Holdings Limited and 
CVC Capital Partners Asia Pacific III Parallel Fund-A, LP.  
    Nomura is sole bookrunner for the transaction. 
    CVC is selling 186 million shares of its holding of 323 
million shares, or 16.1 percent of Jintian. 
    CVC declined to comment. 
($1=7.7544 Hong Kong dollar) 
 
 (Reporting by Elzio Barreto; Writing by Stephen Aldred; Editing 
by Clarence Fernandez) 
 ((stephen.aldred@thomsonreuters.com; +852 2912 6609; Reuters 
Messaging: stephen.aldred.thomsonreuters.com@reuters.net)) 
 
Keywords: CVC CAP PARTNR JINTIAN/BLOCK